BioSpace News Archive

The program has awarded 5 startups in two therapeutic areas, Central Nervous System and Respiratory, with seed investments of up to 100,000 euros and the chance to start a strategic partnership with Zambon

MorphoSys AG reported today that its licensee Janssen has announced that results from the ECLIPSE study demonstrated that Tremfya(R) (guselkumab) was superior to Cosentyx(R) (secukinumab) in treating adults with moderate to severe plaque psoriasis for the primary endpoint of a PASI 90 response at week 48.

Researchers at UCSF recently published research in the journal Science describing their use of a modified version of CRISPR gene editing to stimulate the activity of certain genes, resulting in the prevention of severe obesity in mice who had a genetic predisposition to extreme weight gain.

2nd Deadliest Outbreak in History Highlights the Need for a Safe and Effective Vaccine

CARMAT today announces the appointment of Pascale d’Arbonneau as Chief Financial Officer.

Because many types of prostate cancer are very slow growing and generally diagnosed in older men, so-called “watchful waiting” is often the prescribed treatment plan. Now researchers are saying this may not be the best way.

The rule could have allowed generic manufacturers to independently update safety data on drugs, which could have opened the companies to potential lawsuits over side effects.

In writing literally hundreds of stories this year, two BioSpace writers, Alex Keown and Mark Terry, found certain stories particularly intriguing or impactful. Some of those were such big topics that they were covered over a series of stories. Looking back at 2018, here are their Top 10.

Days after Axovant announced an end to focusing on its legacy small molecule portfolio in favor of gene therapies, the company announced it has licensed worldwide rights to two gene therapy programs from the University of Massachusetts School of Medicine.

Knowing how mutations in cancer cells work will help researchers better understand how they evolve to become resistant to drugs